Pharmaceutical supply - built on reliability and urgency.

Registered
Pharmaceutical Manufacturer, Importer/Exporter

Strict GMP certified
supplier manufacturing
sites

Proven
emergency procurement
capability

Experienced team:
Extensive expertise in Section 21 Procurement.
Proven track-record in New Product Registrations.
Compliance-driven.
Sustainable access to high-quality medicines.

Lamar At a Glance

Market Access Partner

With in-house Commercial, Marketing, and Regulatory Affairs, Quality Assurance, and Quality Control capabilities, we build and manage a portfolio of registered pharmaceutical products, supporting consistent supply to the public and private sectors, and healthcare ecosystem.

Emergency Procurement (Section 21)

Where clinically justified and permitted, South African regulatory pathways such as Section 21 may enable controlled access to unregistered medicines for specific circumstances. Lamar International (Pty) Ltd, in collaboration with SAHPRA, also supports partners in navigating urgent medicine supply shortages in a responsible and compliant manner – subject to applicable approvals and requirements.

Regulatory & Quality Stewardship

We maintain strong relationships with international suppliers and are continuously assessing new products and medical innovations suited to African healthcare needs.

Why Lamar

Credibility is built in the details.

In a market where reliability matters, Lamar is built for long-term partnerships, regulatory discipline, and execution. We are known for practical problem-solving – especially when timelines are tight and supply chains are under pressure.

Quality & Compliance

Quality isn't a claim - it's our system.

Our products are manufactured under strict GMP standards through vetted partners. We prioritise quality assurance, supplier governance, and documentation integrity to support consistent, compliant supply.

Improving access to health in Sub-Saharan Africa

We support better health outcomes by helping healthcare systems and partners access essential medicines and innovations – particularly in Sub-Saharan Africa – through dependable sourcing, compliant pathways, and strong operational execution.